Liver: Carnosic acid could be a new treatment option for patients with NAFLD or the metabolic syndrome

Nature Reviews Gastroenterology and Hepatology

Volumn 8, Issue 3, 2011, Pages 122-

  Greenhill, Claire ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARNOSIC ACID;

ABDOMINAL OBESITY; ADIPOCYTE; ANTIOXIDANT ACTIVITY; CELL DIFFERENTIATION; CELL MATURATION; DRUG EFFICACY; GLUCOSE TOLERANCE; HUMAN; INTRAABDOMINAL FAT; LIPID STORAGE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; NOTE; PRIORITY JOURNAL; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 79952389104     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.9     Document Type: Note

References (1)

1. ORIGINAL ARTICLE Wang, T. et al. Carnosic acid prevents obesity and hepatic steatosis on ob/ob mice. Hepatol. Res. 41, 87-92 (2011)